Forte Biosciences
IPOPublic · Dallas, United States · Founded 2017 · $53.0M raised
- Headquarters
- Dallas, Texas
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- fortebiorx.com
- Total Funding
- $53.0M
- Last Round
- $53.0M Corporate RoundNov 2024
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.
About
Clinical-stage biopharmaceutical company developing live biotherapeutics for autoimmune and inflammatory skin diseases.
Summary
Forte Biosciences is a Biotech company based in Dallas, United States, founded in 2017. It has raised $53.0M in total across 1 round, most recently a $53.0M Corporate Round in Nov 2024. Investors include OrbiMed and BVF Partners.
Funding & Exit History
Jun 2025
Sign up to see all 4 events
Funding: Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/forte-biosciences"><img src="https://indexed.vc/api/badge/company/forte-biosciences" alt="Forte Biosciences on Indexed.vc" width="260" height="76" /></a>